Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

In addition to launching TRYNGOLZA, we are pleased that higher dose Nusinersen is one step closer to the market with the recent FDA and EMA acceptances of Biogen's regulatory submissions.

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) reported its fourth-quarter 2024 earnings, revealing a stronger-than-expected financial performance. The company posted an earnings per share (EPS) of -0. ...

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) reported its fourth-quarter 2024 earnings, revealing a stronger-than-expected financial performance. The company posted an earnings per share (EPS) of -0.66, ...

Small molecules are low molecular weight molecules that include lipids, monosaccharides, second messengers, other natural products and metabolites, as well as drugs and other xenobiotics.

Doctor claims this molecule could help people live longer Biomedical scientist and author Dr. Nathan Bryan explains the health benefits of nitric oxide on 'Fox & Friends'.